Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
68 employees · est. 2019 · Boston, United States
Pyxis Oncology is the older company (2020 vs 2019); Pyxis Oncology is the larger of the two.
Side-by-Side Comparison
| Metric | Valink Therapeutics | Pyxis Oncology |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2019 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Boston, United States |
| Employees | ||
| Employees | 31 | 68 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Seed | Unknown |
| Total Funding | ||
| Total Funding | Not tracked yet | $392.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Drug Discovery and Development, Therapeutic Design and Optimization, Biologics Research, Pipeline Development | development of antibody-drug conjugates, immunotherapy research, clinical program management, oncology-focused drug development |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Researchers, Medical Professionals, Cancer Treatment Facilities, Healthcare Institutions | patients with difficult-to-treat cancers, healthcare professionals, oncologists, medical researchers |
| Taxonomy | ||
| Taxonomy | Antibody-Drug Conjugates, BsADCs, Platform Therapeutics, Oncology, Solid Tumors, Multivalent Antibodies, Bispecific Antibodies, Novel Target Combinations, Protein Technology Platform, Biologics Discovery, Venture Capital-backed, Y Combinator-incubated, University Spin-out | Antibody-Drug Conjugates, Immunotherapy, Cancer Treatment, Biologics, Tumor Targeting, Immune Suppression Overcoming, Tumor Antigen-Specific TILs, Tumor-Infiltrating Lymphocytes, Cold Tumors, Hot Tumors, Tumor Cell Signaling, Antibody-Based Immunotherapies, Oncology Innovation, Therapeutic Development |
| Website | ||
| Website | valinktx.com | pyxisoncology.com |
About Valink Therapeutics
Valink Therapeutics, with its slogan "Making better ADCs," is pioneering the development of novel multivalent bispecific antibody-drug conjugates (bsADCs) designed to revolutionize the treatment of solid tumors and other critical health conditions. The company's innovative approach focuses on non-ob...
About Pyxis Oncology
Pyxis Oncology, founded in 2019, is a biotech innovator based in the United States, focused on transformative cancer therapies. With a mission expressed through their slogan, "Charting a course to therapeutics for difficult-to-treat cancer," Pyxis aims to change the landscape of cancer treatment. T...
We will tell you when either one moves
BounceWatch watches Valink Therapeutics and Pyxis Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Valink Therapeutics and Pyxis Oncology — by email.
Frequently Asked Questions
Compare Valink Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Valink Therapeutics on 22 Mar 2026, and Pyxis Oncology on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.